Gauthier-Rahman S, Akoun G M, Milleron B J, Mayaud C M
Chest Disease Department, Hôpital Tenon, Paris, France.
Chest. 1990 Jan;97(1):238-41. doi: 10.1378/chest.97.1.238.
About 20 cases of beta blocker-associated pneumonitis have been published in the mid-70s, and a case of interstitial pneumonitis has been attributed to propranolol. The pathogenesis of these cases of pneumonitis with or without pleural effusion is not clear. A 59-year-old man developed pneumonitis which showed all the characteristics of a drug-associated pneumonitis due to propranolol: BAL demonstrated a lymphocytosis, the variations of which closely correlated with a provocation test. The LIF appeared to be released by the patient's peripheral blood lymphocytes when cultured with optimal doses of propranolol. Production of LIF by the patients' lymphocytes suggests the existence of a drug-specific cellular immune response in propranolol-associated pneumonitis.
20世纪70年代中期已发表了约20例β受体阻滞剂相关性肺炎的病例,有1例间质性肺炎被认为是由普萘洛尔所致。这些伴有或不伴有胸腔积液的肺炎病例的发病机制尚不清楚。一名59岁男性发生了肺炎,其表现出了由普萘洛尔引起的药物相关性肺炎的所有特征:支气管肺泡灌洗显示淋巴细胞增多,其变化与激发试验密切相关。当用最佳剂量的普萘洛尔培养时,白细胞介素-1似乎由患者外周血淋巴细胞释放。患者淋巴细胞产生白细胞介素-1提示在普萘洛尔相关性肺炎中存在药物特异性细胞免疫反应。